Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab

Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab

Primary liver cancer is characterized by closely related with chronic liver inflammation, thereby reversing hypoxic immunosuppressive microenvironment of tumor cell growth by immunotherapy drug is a potentially effective strategy. Camrelizumab is an anti-PD-1 antibody being developed by Jiangsu Heng...

Full description

Bibliographic Details
Main Authors: Wenling Ye, Lihong Cai, Minjie Zhang, Yali Wu, Huina Sun, Yan-Dong Wang, Yubing Xia
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Immunology
Subjects:
primary liver cancer
immune checkpoint inhibitor
PD-1
Camrelizumab
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1221418/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1221418/full

Similar Items